COVID-19 risk factors: Difference between revisions
Jump to navigation
Jump to search
Sara Haddadi (talk | contribs) |
Sara Haddadi (talk | contribs) |
||
| Line 19: | Line 19: | ||
**[[Cancer patient|Cancer patients]] | **[[Cancer patient|Cancer patients]] | ||
**Individuals in long term care facilities | **Individuals in long term care facilities | ||
** | **Males | ||
***According to a [[systematic review]] and [[Meta-analysis]] males had significantly higher [[mortality]] compared to females ([[OR]] 3.4; 95% [[CI]] 1.2–9.1, P=0.01)<ref name="NasiriHaddadi2020">{{cite journal|last1=Nasiri|first1=Mohammad Javad|last2=Haddadi|first2=Sara|last3=Tahvildari|first3=Azin|last4=Farsi|first4=Yeganeh|last5=Arbabi|first5=Mahta|last6=Hasanzadeh|first6=Saba|last7=Jamshidi|first7=Parnian|last8=Murthi|first8=Mukunthan|last9=Mirsaeidi|first9=Mehdi|title=COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis|journal=Frontiers in Medicine|volume=7|year=2020|issn=2296-858X|doi=10.3389/fmed.2020.00459}}</ref> | ***According to a [[systematic review]] and [[Meta-analysis]] males had significantly higher [[mortality]] compared to females ([[OR]] 3.4; 95% [[CI]] 1.2–9.1, P=0.01)<ref name="NasiriHaddadi2020">{{cite journal|last1=Nasiri|first1=Mohammad Javad|last2=Haddadi|first2=Sara|last3=Tahvildari|first3=Azin|last4=Farsi|first4=Yeganeh|last5=Arbabi|first5=Mahta|last6=Hasanzadeh|first6=Saba|last7=Jamshidi|first7=Parnian|last8=Murthi|first8=Mukunthan|last9=Mirsaeidi|first9=Mehdi|title=COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis|journal=Frontiers in Medicine|volume=7|year=2020|issn=2296-858X|doi=10.3389/fmed.2020.00459}}</ref> | ||
**[[Old age|Elderly]] (those aged 60+) | **[[Old age|Elderly]] (those aged 60+) | ||
Revision as of 00:03, 2 August 2020
|
COVID-19 Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
COVID-19 risk factors On the Web |
|
American Roentgen Ray Society Images of COVID-19 risk factors |
For COVID-19 frequently asked inpatient questions, click here
For COVID-19 frequently asked outpatient questions, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2] Aisha Adigun, B.Sc., M.D.[3]
Overview
Similar to all viral illnesses, exposure is considered the most significant risk factor for infection with Coronavirus disease 2019 (COVID-19). Individuals at risk for the severe form of the disease include elderly (those aged 60+), cardiovascular disease patients, diabetics, chronic respiratory disease patients, hypertensive patients, cancer patients, and individuals in long term care facilities.
Risk Factors
- Similar to all viral illnesses, exposure is considered the most significant risk factor for infection with Coronavirus disease 2019 (COVID-19).
- Individuals at risk for the severe form of the disease include:[1][2][3][4][5][6][7]
- Cardiovascular disease patients
- Diabetics
- Chronic respiratory disease patients
- Hypertensive patients
- Cancer patients
- Individuals in long term care facilities
- Males
- According to a systematic review and Meta-analysis males had significantly higher mortality compared to females (OR 3.4; 95% CI 1.2–9.1, P=0.01)[8]
- Elderly (those aged 60+)
- Individuals ≥80 years showed to have more than 20-fold increased risk of death compared to the 50-59 year olds age group.[9]
- CDC has proposed the following list of conditions that may increase the risk of a severe disease regardless of the individual's age:[10]
- Blood disorders
- Chronic kidney disease
- Chronic liver disease
- Compromised immune system (immunosuppression)
- Current or recent pregnancy in the last two weeks
- Endocrine disorders
- Metabolic disorders
- Heart disease
- Lung disease
- Neurological and neurodevelopmental conditions
- An Israeli based population study with 7,807 participants was published online on the 23rd of July 2020[11]. 10.1% (782) of these patients were COVID-19 positive. The study found that low vitamin D levels may be an independent risk factor for COVID-19 infection and hospitalization.
References
- ↑ http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51. Missing or empty
|title=(help) - ↑ Li, Qun; Guan, Xuhua; Wu, Peng; Wang, Xiaoye; Zhou, Lei; Tong, Yeqing; Ren, Ruiqi; Leung, Kathy S.M.; Lau, Eric H.Y.; Wong, Jessica Y.; Xing, Xuesen; Xiang, Nijuan; Wu, Yang; Li, Chao; Chen, Qi; Li, Dan; Liu, Tian; Zhao, Jing; Liu, Man; Tu, Wenxiao; Chen, Chuding; Jin, Lianmei; Yang, Rui; Wang, Qi; Zhou, Suhua; Wang, Rui; Liu, Hui; Luo, Yinbo; Liu, Yuan; Shao, Ge; Li, Huan; Tao, Zhongfa; Yang, Yang; Deng, Zhiqiang; Liu, Boxi; Ma, Zhitao; Zhang, Yanping; Shi, Guoqing; Lam, Tommy T.Y.; Wu, Joseph T.; Gao, George F.; Cowling, Benjamin J.; Yang, Bo; Leung, Gabriel M.; Feng, Zijian (2020). "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia". New England Journal of Medicine. doi:10.1056/NEJMoa2001316. ISSN 0028-4793.
- ↑ Heymann, David L; Shindo, Nahoko (2020). "COVID-19: what is next for public health?". The Lancet. 395 (10224): 542–545. doi:10.1016/S0140-6736(20)30374-3. ISSN 0140-6736.
- ↑ https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/high-risk-complications.html. Missing or empty
|title=(help) - ↑ Hu, Zhiliang; Song, Ci; Xu, Chuanjun; Jin, Guangfu; Chen, Yaling; Xu, Xin; Ma, Hongxia; Chen, Wei; Lin, Yuan; Zheng, Yishan; Wang, Jianming; Hu, Zhibin; Yi, Yongxiang; Shen, Hongbing (2020). "Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China". Science China Life Sciences. doi:10.1007/s11427-020-1661-4. ISSN 1674-7305.
- ↑ Porcheddu, Rossella; Serra, Caterina; Kelvin, David; Kelvin, Nikki; Rubino, Salvatore (2020). "Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China". The Journal of Infection in Developing Countries. 14 (02): 125–128. doi:10.3855/jidc.12600. ISSN 1972-2680.
- ↑ Wilder-Smith, Annelies; Chiew, Calvin J; Lee, Vernon J (2020). "Can we contain the COVID-19 outbreak with the same measures as for SARS?". The Lancet Infectious Diseases. doi:10.1016/S1473-3099(20)30129-8. ISSN 1473-3099.
- ↑ Nasiri, Mohammad Javad; Haddadi, Sara; Tahvildari, Azin; Farsi, Yeganeh; Arbabi, Mahta; Hasanzadeh, Saba; Jamshidi, Parnian; Murthi, Mukunthan; Mirsaeidi, Mehdi (2020). "COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis". Frontiers in Medicine. 7. doi:10.3389/fmed.2020.00459. ISSN 2296-858X.
- ↑ Williamson, Elizabeth J.; Walker, Alex J.; Bhaskaran, Krishnan; Bacon, Seb; Bates, Chris; Morton, Caroline E.; Curtis, Helen J.; Mehrkar, Amir; Evans, David; Inglesby, Peter; Cockburn, Jonathan; McDonald, Helen I.; MacKenna, Brian; Tomlinson, Laurie; Douglas, Ian J.; Rentsch, Christopher T.; Mathur, Rohini; Wong, Angel Y. S.; Grieve, Richard; Harrison, David; Forbes, Harriet; Schultze, Anna; Croker, Richard; Parry, John; Hester, Frank; Harper, Sam; Perera, Rafael; Evans, Stephen J. W.; Smeeth, Liam; Goldacre, Ben (2020). "OpenSAFELY: factors associated with COVID-19 death in 17 million patients". Nature. doi:10.1038/s41586-020-2521-4. ISSN 0028-0836.
- ↑ (PDF) https://www.cdc.gov/coronavirus/2019-ncov/downloads/community-mitigation-strategy.pdf. Missing or empty
|title=(help) - ↑ "Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study - Merzon - - The FEBS Journal - Wiley Online Library".